↓ Skip to main content

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, March 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#44 of 204)
  • High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

policy
1 policy source
twitter
7 tweeters

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference
Published in
Journal of Pharmaceutical Policy and Practice, March 2016
DOI 10.1186/s40545-016-0056-8
Pubmed ID
Authors

Sabine Vogler, Nina Zimmermann, Alessandra Ferrario, Veronika J. Wirtz, Kees de Joncheere, Hanne Bak Pedersen, Guillaume Dedet, Valérie Paris, Aukje K. Mantel-Teeuwisse, Zaheer-Ud-Din Babar

Abstract

In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for medicines. The research presented highlighted that commonly used pharmaceutical pricing and reimbursement policies are not sufficiently effective to address current challenges. Conference participants called for fundamental reforms to ensure access to medicines, particularly to new and potentially more effective and/or safe medicines, while safeguarding the financial sustainability of health systems and working towards universal health coverage.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 42%
Researcher 4 11%
Student > Ph. D. Student 4 11%
Student > Postgraduate 2 6%
Student > Bachelor 2 6%
Other 3 8%
Unknown 6 17%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 8 22%
Medicine and Dentistry 6 17%
Economics, Econometrics and Finance 4 11%
Nursing and Health Professions 3 8%
Business, Management and Accounting 3 8%
Other 5 14%
Unknown 7 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2018.
All research outputs
#2,297,805
of 15,097,898 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#44
of 204 outputs
Outputs of similar age
#50,011
of 266,258 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 1 outputs
Altmetric has tracked 15,097,898 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 204 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 266,258 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them